Literature DB >> 30410661

Immune Checkpoint Inhibitor-Related Cardiotoxicity.

Barry Trachtenberg1, Fahd Hussain2, Akash Mukherjee1, Raquel Araujo-Gutierrez1, Sai Ravi Kiran Pingali1.   

Abstract

Entities:  

Keywords:  cardiotoxicity; checkpoint inhibitor; immunotherapy; myocarditis

Mesh：

Year:  2018        PMID： 30410661      PMCID： PMC6217570          DOI： 10.14797/mdcj-14-3-e1

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


× No keyword cloud information.
  9 in total

1.  New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma.

Authors:  Juliane Behling; Joachim Kaes; Thomas Münzel; Stephan Grabbe; Carmen Loquai
Journal:  Melanoma Res       Date:  2017-04       Impact factor: 3.599

2.  Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung.

Authors:  H Semper; F Muehlberg; J Schulz-Menger; M Allewelt; C Grohé
Journal:  Lung Cancer       Date:  2016-07-01       Impact factor: 5.705

Review 3.  Inflammatory Cardiomyopathic Syndromes.

Authors:  Barry H Trachtenberg; Joshua M Hare
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

Authors:  H Nishimura; T Okazaki; Y Tanaka; K Nakatani; M Hara; A Matsumori; S Sasayama; A Mizoguchi; H Hiai; N Minato; T Honjo
Journal:  Science       Date:  2001-01-12       Impact factor: 47.728

5.  Cardiac Toxicity of Immune Checkpoint Inhibitors: Cardio-Oncology Meets Immunology.

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Carlo G Tocchetti
Journal:  Circulation       Date:  2017-11-21       Impact factor: 29.690

6.  Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.

Authors:  Marion Escudier; Jennifer Cautela; Nausicaa Malissen; Yann Ancedy; Morgane Orabona; Johan Pinto; Sandrine Monestier; Jean-Jacques Grob; Ugo Scemama; Alexis Jacquier; Nathalie Lalevee; Jeremie Barraud; Michael Peyrol; Marc Laine; Laurent Bonello; Franck Paganelli; Ariel Cohen; Fabrice Barlesi; Stephane Ederhy; Franck Thuny
Journal:  Circulation       Date:  2017-11-21       Impact factor: 29.690

7.  Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

Authors:  Syed S Mahmood; Michael G Fradley; Justine V Cohen; Anju Nohria; Kerry L Reynolds; Lucie M Heinzerling; Ryan J Sullivan; Rongras Damrongwatanasuk; Carol L Chen; Dipti Gupta; Michael C Kirchberger; Magid Awadalla; Malek Z O Hassan; Javid J Moslehi; Sachin P Shah; Sarju Ganatra; Paaladinesh Thavendiranathan; Donald P Lawrence; John D Groarke; Tomas G Neilan
Journal:  J Am Coll Cardiol       Date:  2018-03-19       Impact factor: 24.094

Review 8.  Cardiovascular Toxicities Associated with Cancer Immunotherapies.

Authors:  Daniel Y Wang; Gosife Donald Okoye; Thomas G Neilan; Douglas B Johnson; Javid J Moslehi
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

9.  Fulminant Myocarditis with Combination Immune Checkpoint Blockade.

Authors:  Douglas B Johnson; Justin M Balko; Margaret L Compton; Spyridon Chalkias; Joshua Gorham; Yaomin Xu; Mellissa Hicks; Igor Puzanov; Matthew R Alexander; Tyler L Bloomer; Jason R Becker; David A Slosky; Elizabeth J Phillips; Mark A Pilkinton; Laura Craig-Owens; Nina Kola; Gregory Plautz; Daniel S Reshef; Jonathan S Deutsch; Raquel P Deering; Benjamin A Olenchock; Andrew H Lichtman; Dan M Roden; Christine E Seidman; Igor J Koralnik; Jonathan G Seidman; Robert D Hoffman; Janis M Taube; Luis A Diaz; Robert A Anders; Jeffrey A Sosman; Javid J Moslehi
Journal:  N Engl J Med       Date:  2016-11-03       Impact factor: 91.245
  9 in total
  1 in total

1.  Electrocardiographic features of immune checkpoint inhibitor associated myocarditis.

Authors:  Daniel A Zlotoff; Malek Z O Hassan; Amna Zafar; Raza M Alvi; Magid Awadalla; Syed S Mahmood; Lili Zhang; Carol L Chen; Stephane Ederhy; Ana Barac; Dahlia Banerji; Maeve Jones-O'Connor; Sean P Murphy; Merna Armanious; Brian J Forrestal; Michael C Kirchberger; Otavio R Coelho-Filho; Muhammad A Rizvi; Gagan Sahni; Anant Mandawat; Carlo G Tocchetti; Sarah Hartmann; Hannah K Gilman; Eduardo Zatarain-Nicolás; Michael Mahmoudi; Dipti Gupta; Ryan Sullivan; Sarju Ganatra; Eric H Yang; Lucie M Heinzerling; Franck Thuny; Leyre Zubiri; Kerry L Reynolds; Justine V Cohen; Alexander R Lyon; John Groarke; Paaladinesh Thavendiranathan; Anju Nohria; Michael G Fradley; Tomas G Neilan
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.